Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 28
- Next page
Title | Authors | Year | Journal Sort descending | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Older patients with myeloma derive similar benefit from autologous transplantation | Sharma M, Zhang MJ, Zhong X, Abidi MH, Akpek G, Bacher U, Callander NS, Dispenzieri A, Freytes CO, Fung HC, Gale RP, Gasparetto C, Gibson J, Holmberg LA, Kindwall-Keller TL, Klumpp TR, Krishnan AY, Landau HJ, Lazarus HM, Lonial S, Maiolino A, Marks DI, Mehta P, Mikhael Med JR, Nishihori T, Olsson R, Ramanathan M, Roy V, Savani BN, Schouten HC, Scott E, Tay J, To LB, Vesole DH, Vogl DT, Hari P | 2014 | Biol Blood Marrow Transplant | View Older patients with myeloma derive similar benefit from autologous transplantation | Health care providers | Clinical research |
Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation | Pilon S, Jedrysiak D, Sheppard D, Bredeson CN, Tay J, Allan DS | 2015 | Biol Blood Marrow Transplant | View Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation | Health care providers | Clinical research |
Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Adams Z, Morris G, Campbell T, Mostert K, Dibdin N, Fearon M, Elmoazzen H, Mercer D, Young K, Allan D | 2018 | Biol Blood Marrow Transplant | View Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Blood operators | Clinical research |
Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value–Tailored Approach | Sheppard D, Tay J, Palmer D, Xenocostas A, Doulaverakis C, Huebsch L, McDiarmid S, Tinmouth A, Mallick R, Martin L, Birch P, Hamelin L, Allan D, Bredeson C | 2015 | Biol Blood Marrow Transplant | View Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value–Tailored Approach | Health care providers | New or improved product or process |
Low-dose antithymocyte globulin for graft-versus-host-disease prophylaxis in matched unrelated allogeneic hematopoietic stem cell transplantation | Bryant A, Mallick R, Huebsch L, Allan D, Atkins H, Anstee G, Sabloff M, Scrivens N, Maze D, Bredeson C, Kekre N | 2017 | Biol Blood Marrow Transplant | View Low-dose antithymocyte globulin for graft-versus-host-disease prophylaxis in matched unrelated allogeneic hematopoietic stem cell transplantation | Health care providers | Clinical research |
Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood-Derived Cells | Damien P, Allan DS | 2015 | Biol Blood Marrow Transplant | View Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood-Derived Cells | Health care providers | Other |
Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence | Rizk M, Monaghan M, Shorr R, Kekre N, Bredeson CN, Allan DS | 2016 | Biol Blood Marrow Transplant | View Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence | Researchers | Basic research |
Development and Evaluation of a Whiteboard Video Series to Support the Education and Recruitment of Committed Unrelated Donors for Hematopoietic Stem Cell Transplantation | Li EW, Lee A, Vaseghi-Shanjani M, Anagnostopoulos A, Jagelaviciute G, Kum E, Petraszko T, Elmoazzen H, Allan D, Fingrut W | 2020 | Biol Blood Marrow Transplant | View Development and Evaluation of a Whiteboard Video Series to Support the Education and Recruitment of Committed Unrelated Donors for Hematopoietic Stem Cell Transplantation | Health care providers | New or improved product or process |
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial | Atkins HL, Bowman M, Allan D, Anstee G, Arnold DL, Bar-Or A, Bence-Bruckler I, Birch P, Bredeson C, Chen J, Fergusson D, Halpenny M, Hamelin L, Huebsch L, Hutton B, Laneuville P, Lapierre Y, Lee H, Martin L, McDiarmid S, O'Connor P, Ramsay T, Sabloff M, Walker L, Freedman MS | 2016 | Lancet | View Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial | Researchers | Clinical research |
Challenges in the management of the blood supply | Williamson LM, Devine DV | 2013 | Lancet | View Challenges in the management of the blood supply | Blood operators | Other |
Transfusion reactions: prevention, diagnosis, and treatment | Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, Apelseth TO, Popovsky M, Stanworth SJ, Tinmouth A, Van De Watering L, Waters JH, Yazer M, Ziman A | 2016 | Lancet | View Transfusion reactions: prevention, diagnosis, and treatment | Health care providers | Clinical research |
Transfusion-transmitted malaria: is hope around the corner? | O'Brien SF | 2016 | Lancet | View Transfusion-transmitted malaria: is hope around the corner? | Researchers | Other |
Chapter 33: Synthesis of N-(4-Methoxybenzyl)-2-(α-d-glucopyranosyl) acetamide | Roy R, Vidal S, Briard JG, Shiao TC, Ben RN | 2015 | Carbohydrate Chemistry: Proven Synthetic Methods, Volume 3 | View Chapter 33: Synthesis of N-(4-Methoxybenzyl)-2-(α-d-glucopyranosyl) acetamide | Researchers | Basic research |
Chapter 5 - Platelet microRNAs | Provost P | 2013 | Platelets (Third Edition) | View Chapter 5 - Platelet microRNAs | Researchers | Other |
Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris | de Bold MK, Sheffield WP, Martinuk A, Bhakta V, Eltringham-Smith L, de Bold AJ | 2012 | Regul Pept | View Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris | Researchers | Basic research |
Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells | Evren S, Wan S, Ma XZ, Fahim S, Mody N, Sakac D, Jin T, Branch DR | 2013 | Genomics | View Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells | Researchers | Basic research |
Characterization of the growth modulatory activities of osteoblast conditioned media on cord blood progenitor cells | Abu-Khader A, Pasha R, Ward GCD, Boisjoli G, Pineault N | 2016 | Cytotechnology | View Characterization of the growth modulatory activities of osteoblast conditioned media on cord blood progenitor cells | Researchers | Basic research |
Chemoenzymatic Synthesis of a Type 2 Blood Group A Tetrasaccharide and Development of High-throughput Assays Enables a Platform for Screening Blood Group Antigen-cleaving Enzymes | Kwan DH, Ernst S, Kotzler MP, Withers SG | 2015 | Glycobiology | View Chemoenzymatic Synthesis of a Type 2 Blood Group A Tetrasaccharide and Development of High-throughput Assays Enables a Platform for Screening Blood Group Antigen-cleaving Enzymes | Researchers | Basic research |
Chloride and other electrolyte concentrations in commonly available 5% albumin products | Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B, on behalf of The Canadian Critical Care Trials Group | 2018 | Crit Care Med | View Chloride and other electrolyte concentrations in commonly available 5% albumin products | Health care providers | Clinical research |
The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis | Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, Rimmer E, Houston BL, McIntyre L, Fox-Robichaud AE, Hebert P, Cook DJ, Fergusson DA | 2015 | Crit Care Med | View The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis | Health care providers | Clinical research |
Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia | Iba T, Levy JH, Warkentin TE | 2022 | Crit Care Med | View Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia | Health care providers | Benchmarking and standard setting |
Chloride and other electrolyte concentrations in commonly available 5% albumin products | Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B | 2018 | Crit Care Med | View Chloride and other electrolyte concentrations in commonly available 5% albumin products | Researchers | Clinical research |
The authors reply | Iba T, Levy JH, Warkentin TE | 2022 | Crit Care Med | View The authors reply | Researchers | Clinical research |
Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies | Semple JW, McVey MJ, Kim M, Rebetz J, Kuebler WM, Kapur R | 2018 | Crit Care Med | View Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies | Researchers | Basic research |
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chassé M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A, Marceau D, Huang A, Carr H, Lin Y, Lall R, Graham C, Arsenault C, Sales V, Sidhu D, Semret M, Hamm C, Arhanchiague E, Solh Z, Srour N, Soliman K, Yee C, Laroche V, Nahirniak S, Greenaway C, Pai M, Côté A, Tsang JLY, Cserti-Gazdewich C, Talbot D, Poulin S, Guimaraes R, Rushton-Marovac M, Langlois A, Ning S, Shih A, Boileau M, Singh H, Ledingham D, Ponnampalam A, Yan M, Prokopchuk-Gauk O, Poirier A, Girouard G, Pavenski K, Drouin O, Harris D, Durand M, Rimmer E, Ovakim D, Ménard F, Cuccarolo G, Carruthers J, Lucier K, Arsenault V, Auclair M-C, Avram M, Brassard M, Cerro S, Martinez V, Morin J, Saint-Jacques M, Veillette M, Armali C, Kron A, Modi D, Duncan J, Justumus P, John MS, St-Onge G, Hadzi-Tosev M, Dion P-M, McGillivary L, de Moulliac AV, Nyman SA, Perilli S, Van Vliet PJ, Lane S, Pavenski K, Pereira R, Sirotich E, Abelson J, Greene S, Khandelwal A, Thakar S, Longo S, Anand SP, Benlarbi M, Bourassa C, Boutin M, Descôteaux-Dinelle J, Gendron-Lepage G, Goyette G, Laumaea A, Medjahed H, Prévost J, Richard J, Kaufmann D, Brunet-Ratnasingham E, Chaumont N, Drebot M, Robinson A, Mendoza E, Dimitrova K, Manguiat K, Phillipson C, Chan M, Evans D, Lin J, Boyer L, Cloutier M, Drouin M, Ducas É, Dussault N, Fournier M-J, Landy P, Nolin M-È, Perreault J, Tremblay T, Nazy I, Xie F, Liu D, Wong M, Silverio G, Walkus K, Barton M, Haveman K, Mueller D, Scott A, Moher M, Wood G, Roarty T, Auld F, Carney G, Thomson V, Onell R, Walley K, Donohoe K, Brunk C, Hernandez G, Jacobucci T, Lazosky L, Mann P, Raval G, Zampieri LA, Sekhon M, Wright A, James N, Chang G, Chen R, Deol K, Gantioqui J, Larsen E, Ramdin N, Roche M, Rosinski K, Sham L, Storms M, Gillrie M, Mahe E, Suryanarayan D, Ugarte-Torres A, Robinson T, Gibbs M, Hewsgirard J, Holmes M, McCarthy J, Ody M, Doucette K, Sligl W, Sonpar A, Robertson K, Narayan J, Ravindran L, Stewart B, Zapernick L, Lee S, Sy E, Wong A, Gryzb K, Craddock S, Fuchs D, Myrah D, Sunny S, Harding SR, Kogilwaimath S, Hodgson N, Johnson D, Meier S, Thomson K, Heendeniya A, Houston B, Kenyan Y, Lother S, Olafson K, Rush B, Wuerz T, Solvason D, Albensi L, Alias S, Choi N, Curtis L, Hutmacher M, Kashani H, Lane D, Marten N, Pronyk-Ward T, Rigaux L, Silva R, Tays Q, Naidu R, Mathews J, Mai M, Miceli V, Molson L, Radhakrishnan G, Schaefer L, Haddad M, Landry S, Chernish R, Kruisselbrink R, Liu T, Jeromin J, Siddiqui A, Girolametto C, Krokoszynski K, Main C, Fox-Robichaud A, Rochwerg B, Kruja E, Ellingham D, Sampat D, Tang N, Leto D, Karunakaran M, Ricciuto D, Fusco K, Ghate T, Robinson H, Ball I, Shalhoub S, Slessarev M, Silverman M, Nano E, Bentall T, Campbell E, Kinney J, Parvathy S, Fera E, Delfa AL, Nadarajah J, Solow H, Mendoza E, Engel K, Monaco D, Kononow L, Suntharalingam S, Fralick M, Munshi L, Saeed S, Hajjaj O, Hsu E, Ali K, Duan E, Farjou G, Jenson L, Salib M, Patterson L, Anant S, Ding J, Jomy J, Das P, Geagea A, the Concor-Study Group | 2021 | Nat Med | View Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Health care providers | Clinical research |
Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 | Bégin P, Callum J, Cook R, Jamula E, Liu Y, Finzi A, Arnold DM | 2022 | Nat Med | View Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 | Researchers | Clinical research |
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis | Murphy AJ, Bijl N, Yvan-Charvet L, Welch CB, Bhagwat N, Reheman A, Wang Y, Shaw JA, Levine RL, Ni H, Tall AR, Wang N | 2013 | Nat Med | View Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis | Researchers | Basic research |
Circulatory Death Determination in Uncontrolled Organ Donors: A Panel Viewpoint | Bernat JL, Bleck TP, Blosser SA, Bratton SL, Capron AM, Cornell D, Devita MA, Fulda GJ, Glazier AK, Gries CJ, Mathur M, Nakagawa TA, Shemie SD | 2014 | Ann Emerg Med | View Circulatory Death Determination in Uncontrolled Organ Donors: A Panel Viewpoint | Health care providers | Other |
A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Grunau B, O’Brien SF, Kirkham TL, Helmer J, Demers PA, Asamoah-Boaheng M, Drews SJ, Karim ME, Srigley JA, Sediqi S, O’Neill D, Drennan IR, Goldfarb DM | 2022 | Ann Emerg Med | View A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Researchers | Clinical research |
Comparison of detection methods for cell surface globotriaosylceramide | Kim M, Binnington B, Sakac D, Fernandes KR, Shi SP, Lingwood CA, Branch DR | 2011 | J Immunol Methods | View Comparison of detection methods for cell surface globotriaosylceramide | Researchers | Basic research |
Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity | Bhakta V, Gierczak RF, Sheffield WP | 2013 | J Biotechnol | View Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity | Researchers | Basic research |
Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Eltringham-Smith LJ, Bhakta V, Sheffield WP | 2021 | J Biotechnol | View Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Researchers | Basic research |
Corrigendum to "Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity" [J. Biotechnol. 208 (2015) 54-62] | Gierczak RF, Bhakta V, Xie M, Sheffield WP | 2020 | J Biotechnol | View Corrigendum to "Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity" [J. Biotechnol. 208 (2015) 54-62] | Researchers | Basic research |
Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity? | Gierczak RF, Bhakta V, Xie M, Sheffield WP | 2015 | J Biotechnol | View Comparison of mammalian and bacterial expression library screening to detect recombinant alpha-1 proteinase inhibitor variants with enhanced thrombin inhibitory capacity? | Researchers | Basic research |
Comparison of methods for the purification of alpha-1 acid glycoprotein from human plasma | McCurdy TR, Bhakta V, Eltringham-Smith LJ, Gataiance S, Fox-Robichaud AE, Sheffield WP | 2011 | J Biomed Biotechnol | View Comparison of methods for the purification of alpha-1 acid glycoprotein from human plasma | Researchers | Basic research |
In vivo clearance of alpha-1 acid glycoprotein is influenced by the extent of its N-linked glycosylation and by its interaction with the vessel wall | McCurdy TR, Bhakta V, Eltringham-Smith LJ, Gataiance S, Fox-Robichaud AE, Sheffield WP | 2012 | J Biomed Biotechnol | View In vivo clearance of alpha-1 acid glycoprotein is influenced by the extent of its N-linked glycosylation and by its interaction with the vessel wall | Researchers | Basic research |
Compatibility of Lactated Ringer's Solution human blood products containing red blood cells: a systematic review protocol | Wolfe D, English S, Fergusson D, Kanji S, Lalu M, Mendis N, Tinmouth A, McIntyre L | 2016 | OHRI Publications | View Compatibility of Lactated Ringer's Solution human blood products containing red blood cells: a systematic review protocol | Researchers | Clinical research |
Don autologue préopératoire | Pambrun C | 2017 | Guide de la pratique transfusionnelle | View Don autologue préopératoire | Health care providers | Benchmarking and standard setting |
Troubles de l'hémostase et angioedéme héréditaire | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Troubles de l'hémostase et angioedéme héréditaire | Health care providers | Other |
Administration de produits sanguins | O'Reilly C | 2021 | Guide de la pratique transfusionnelle | View Administration de produits sanguins | Health care providers | Benchmarking and standard setting |
Les concentrés de facteurs de coagulation | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Les concentrés de facteurs de coagulation | Health care providers | Other |
Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Goldman M, Drews S, Devine D | 2019 | Guide de la pratique transfusionnelle | View Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W, Ning S | 2022 | Guide de la pratique transfusionnelle | View Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Composants sanguins négatifs pour les anti-CMV, irradiés et lavés | Prokopchuk-Gauk O, Solh Z | 2017 | Guide de la pratique transfusionnelle | View Composants sanguins négatifs pour les anti-CMV, irradiés et lavés | Health care providers | Benchmarking and standard setting |
Réduction des agents pathogènes dans les produits de fractionnement | Bigham M | 2019 | Guide de la pratique transfusionnelle | View Réduction des agents pathogènes dans les produits de fractionnement | Health care providers | Benchmarking and standard setting |
Épreuves prétransfusionnelles | Lane D | 2017 | Guide de la pratique transfusionnelle | View Épreuves prétransfusionnelles | Health care providers | Benchmarking and standard setting |
Chapitre 14. Aphérèse thérapeutique | Oliver M, Patriquin C | 2023 | Guide de la pratique transfusionnelle | View Chapitre 14. Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Zeller M, Petraszko T | 2018 | Guide de la pratique transfusionnelle | View Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Health care providers | Other |
Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Épreuves prétransfusionnelles | Duncan J | 2020 | Guide de la pratique transfusionnelle | View Épreuves prétransfusionnelles | Health care providers | Benchmarking and standard setting |